late
decemb
chines
physician
identifi
seri
pneumonia
case
wuhan
inhabit
megac
traffic
hub
central
china
infect
epidemiolog
associ
seafood
wet
market
citi
wet
market
mean
live
dead
anim
sold
rais
suspicion
anoth
zoonot
viru
infect
spill
human
popul
similar
sever
acut
respiratori
syndrom
sar
epidem
also
start
live
anim
market
sar
viral
sourc
trace
back
bat
coronaviru
civet
potenti
intermedi
host
novel
wuhan
viru
figur
differ
name
novel
coronaviru
research
literatur
intern
committe
taxonomi
virus
diseas
denomin
name
indic
repres
coronaviru
one
might
argu
whether
new
instead
novel
coronaviru
better
term
sinc
complet
differ
relat
sar
coronaviru
other
find
suggest
close
relat
sar
viru
possibl
lead
confus
jiang
et
al
wuhan
viru
name
chang
chang
charact
epidem
overview
provid
snapshot
scientif
research
literatur
topic
moment
write
februari
within
record
time
less
month
novel
coronaviru
identifi
isol
sequenc
three
group
chines
scientist
larg
consortium
coordin
w
tan
chines
center
diseas
control
prevent
chines
cdc
obtain
eight
complet
viral
genom
sequenc
nine
patient
either
direct
rna
isol
sequenc
bronchoalveolar
lavag
fluid
balf
classic
viru
isol
human
airway
epitheli
cell
lu
et
al
eight
genom
show
sequenc
ident
ie
four
nucleotid
differ
nucleotidelong
singlestrand
rna
genom
level
viral
genom
ident
isol
differ
human
subject
unusu
rna
viru
circul
long
time
human
popul
observ
suggest
recent
singl
spillov
event
anim
sourc
human
geneticist
estim
event
might
occur
novemb
closest
rel
new
viru
coronavirus
isol
bat
eastern
china
share
sequenc
ident
new
isol
therefor
viral
taxonomist
consid
novel
coronaviru
new
viral
speci
belong
clade
sarbecoviru
group
acronym
sar
compris
betacoronavirus
sar
viru
new
isol
share
even
less
name
sequenc
ident
bat
still
consid
like
sourc
novel
coronaviru
bat
alreadi
hibern
time
onset
epidem
bat
sold
huanan
food
market
wuhan
suggest
intermedi
anim
host
adapt
human
transmiss
might
occur
live
hedgehog
badger
snake
turtledov
sold
huanan
market
claim
made
yet
substanti
snake
pangolin
intermedi
host
creat
coronaviru
recombin
event
w
tan
colleagu
constitut
china
novel
coronaviru
investig
research
team
describ
subsequ
isol
coronavirus
three
patient
wuhan
test
neg
viral
four
bacteri
respiratori
pathogen
virus
close
relat
earlier
nine
patient
human
airway
epitheli
cell
cytopath
effect
viru
lack
cilium
beat
anoth
group
led
yz
zhang
zoonosi
group
chines
cdc
beij
determin
genom
close
relat
coronaviru
deep
metatranscriptom
sequenc
bronchoalveolar
fluid
patient
work
seafood
market
wuhan
wu
et
al
analysi
cell
receptor
interact
viral
spike
gene
show
indic
recombin
event
protein
model
suggest
human
angiotensinconvert
enzym
ii
protein
receptor
zl
shi
wuhan
institut
virolog
collabor
present
detail
character
virus
detect
seven
patient
wuhan
suffer
sever
pneumonia
six
profession
associ
local
food
market
metagenom
balf
yield
coronavirus
share
sequenc
ident
patient
coronaviru
isol
wuhan
use
primer
correspond
region
gene
scientist
develop
sensit
outbreakspecif
pcr
test
provid
diagnost
tool
viru
detect
balf
altern
oral
swab
patient
one
patient
research
demonstr
igm
seroconvers
follow
igg
seroconvers
use
elisa
techniqu
viral
nucleocapsid
target
antigen
three
patient
show
specif
igm
respons
indic
acut
infect
serolog
evid
import
sinc
full
set
koch
postul
identif
new
pathogen
yet
fulfil
one
patient
isol
viru
caus
cytopath
effect
establish
vero
cell
line
day
incub
virusinfect
cell
stain
specif
antibodi
observ
fluoresc
microscopi
allow
establish
viru
neutral
test
patient
develop
neutral
serum
antibodi
hela
cell
could
infect
novel
coronaviru
cell
line
becam
suscept
express
protein
human
bat
civet
mous
origin
indic
novel
coronaviru
use
protein
cell
receptor
sar
coronaviru
epidem
zhang
et
al
compar
novel
coronaviru
genom
isol
patient
three
chines
citi
wuhan
zhejiang
guangdong
thailand
contact
wuhan
genom
similar
could
still
classifi
six
genogroup
suggest
mutat
accumul
within
patient
current
outbreak
curious
basal
genogroup
detect
guangdong
wuhan
isol
anoth
group
indepth
annot
genom
novel
coronavirus
sar
viru
identifi
amino
acid
substitut
affect
predict
protein
viral
genom
wu
peng
et
al
one
studi
focus
case
patient
hospit
wuhan
januari
laboratoryconfirm
infect
huanget
al
earliest
phase
outbreak
patient
mostli
male
half
underli
diseas
expos
huanan
seafood
market
common
present
symptom
fever
cough
myalgia
fatigu
dyspnoea
labour
difficult
breath
develop
acut
respiratori
distress
syndrom
ard
seen
patient
need
transfer
intens
care
unit
icu
die
patient
show
lymphopenia
reduct
lymphocyt
circul
blood
sign
cytokin
storm
followup
studi
investig
patient
jinyintan
hospit
wuhan
januari
januari
patient
pcrconfirm
infect
chen
et
al
next
phase
epidem
fewer
patient
exposur
huanan
seafood
market
still
predominantli
male
averag
age
year
half
suffer
chronic
diseas
predomin
clinic
manifest
patient
fever
cough
short
breath
imag
techniqu
show
bilater
pneumonia
case
seventeen
per
cent
develop
ard
worsen
lead
death
multipl
organ
failur
third
report
patient
confirm
novel
coronaviru
infect
admit
januari
zhongnan
hospit
wuhan
report
differ
previou
two
import
respect
cohort
patient
report
exposur
huanan
seafood
market
gender
ratio
significantli
bias
present
symptom
fever
fatigu
dri
cough
follow
anorexia
myalgia
dyspnoea
bilater
shadow
ground
glass
opac
reveal
imag
techniqu
lung
patient
overal
patient
need
transfer
icu
die
half
patient
show
comorbid
hypertens
cardiovascular
diseas
diabet
notabl
possibl
infect
hospit
includ
healthcar
worker
februari
nine
case
infect
report
infant
year
china
infect
famili
member
infant
mild
form
diseas
wei
et
al
plan
public
health
measur
basic
transmiss
data
novel
coronaviru
essenti
first
confirm
case
wuhan
provid
data
first
epidemiolog
analysi
li
et
al
kept
mind
viru
might
evolv
epidem
chang
properti
three
earli
phase
infect
jan
chang
averag
age
seen
year
case
year
age
observ
male
domin
among
patient
disappear
degre
wet
market
exposur
patient
drop
time
addit
patient
contact
person
show
respiratori
symptom
report
fewer
case
scientist
calcul
mean
incub
period
day
display
long
tail
percentil
day
comparison
index
case
secondari
case
five
cluster
yield
serial
interv
day
onset
ill
medic
visit
hospit
admiss
day
elaps
respect
wuhan
epidem
show
doubl
time
day
cluster
analysi
basic
reproduct
number
estim
ie
case
led
averag
new
infect
anoth
report
investig
case
famili
shenzhen
visit
rel
wuhan
one
wuhan
rel
develop
fever
cough
dyspnoea
four
day
arriv
famili
member
shenzhen
four
rel
develop
respiratori
symptom
led
hospit
two
six
shenzhen
famili
visitor
four
adult
develop
symptom
fever
cough
weak
diarrhoea
day
wuhan
visit
two
children
remain
unaffect
notabl
famili
member
remain
shenzhen
contract
diseas
four
day
return
visitor
wuhan
shenzhen
data
evid
effici
humantohuman
viru
transmiss
viru
detect
nasopharyng
half
throat
swab
singl
serum
sampl
urin
stool
sampl
famili
cluster
import
easi
sampl
viru
diagnost
hospit
patient
hongkong
posit
pcr
viru
detect
selfcollect
saliva
te
et
al
viral
load
rang
viral
copi
per
ml
saliva
decreas
durat
hospit
one
patient
still
detect
day
hospit
anoth
studi
extend
epidemiolog
analysi
infect
patient
live
outsid
wuhan
recent
travel
histori
wuhan
backer
et
al
cohort
allow
estim
mean
incub
period
day
upper
estim
rang
day
import
determin
appropri
durat
quarantin
novel
coronaviru
spread
rapidli
januari
first
patient
report
west
coast
unit
state
patient
develop
respiratori
symptom
famili
visit
wuhan
holshu
et
al
hospit
patient
develop
diarrhoea
stool
weakli
virusposit
observ
import
sinc
could
indic
gut
tropism
addit
lung
tropism
unusu
coronaviru
one
might
therefor
count
chang
symptomatolog
unfold
current
epidem
necessit
public
health
measur
faecalor
transmiss
danchin
et
al
scenario
unlik
sinc
host
receptor
novel
coronaviru
highli
express
gut
enterocyt
liang
et
al
chang
symptomatolog
alreadi
seen
chines
patient
outsid
wuhan
among
first
patient
beij
upper
airway
congest
domin
find
chang
et
al
diseas
laboratoryconfirm
patient
zhejiang
provinc
show
mostli
mild
moder
diseas
diarrhoea
one
patient
need
icu
xu
et
al
analys
case
overal
case
fatal
rate
cfr
calcul
howev
analysi
limit
case
outsid
hubei
provinc
wuhan
locat
cfr
wu
mcgoogan
possibl
suggest
chang
epidem
milder
diseas
larger
chain
transmiss
vetter
et
al
januari
two
citizen
germani
develop
symptom
becam
meet
chines
busi
partner
becam
ill
flight
back
china
two
subject
develop
symptom
contact
one
infect
german
notabl
person
develop
symptom
report
suggest
infect
person
infect
contact
person
incub
period
roth
et
al
wu
leung
estim
nation
global
spread
novel
coronaviru
basi
air
train
traffic
data
wuhan
account
strict
metropolitanwid
quarantin
measur
impos
wuhan
januari
use
infect
metapopul
model
accord
calcul
suffici
number
infect
subject
alreadi
export
major
chines
citi
infect
subject
five
citi
start
secondari
local
epidem
peak
wuhan
epidem
predict
april
local
epidem
peak
chines
citi
would
lag
week
transmiss
could
reduc
restrict
peopl
mobil
magnitud
epidem
could
reduc
peak
epidem
would
delay
one
month
one
major
unknown
factor
model
season
novel
coronaviru
infect
respiratori
infect
typic
winter
infect
declin
warm
season
research
avail
preprint
lai
et
al
estim
infect
subject
wuhan
travel
intern
destin
thailand
japan
lead
list
public
health
measur
must
therefor
also
taken
countri
contain
intern
spread
epidem
epidem
also
reach
europ
unexplain
focu
northern
itali
particularli
worrisom
spread
infect
african
countri
mani
region
close
econom
connect
china
insuffici
hospit
public
health
resourc
assur
effici
contain
measur
gilbert
et
al
risk
transmiss
africa
south
america
howev
epidemiologist
consid
low
haider
et
al
current
unclear
whether
transmiss
mute
agroeconomi
lower
popul
densiti
far
chines
physician
develop
empir
treatment
triag
algorithm
base
experi
patient
wuhan
zhang
et
al
triag
scheme
propos
separ
patient
receiv
home
treatment
receiv
treatment
regular
commun
acquir
pneumonia
suspect
viral
pneumonia
case
test
novel
coronaviru
isol
observ
case
dyspnoea
hypoxia
develop
supplement
oxygen
suppli
given
viral
pneumonia
patient
treat
arbidol
approv
russia
china
influenza
treatment
diagnosi
novel
coronaviru
confirm
patient
transfer
special
design
hospit
efficaci
arbidol
coronaviru
howev
well
substanti
scientif
clinic
emerg
condit
call
need
speed
drug
develop
promis
approach
repurpos
drug
tri
coronavirus
previou
outbreak
sar
middl
east
respiratori
syndrom
mer
coronaviru
li
de
clercq
mer
contrast
sar
coronaviru
zoonosi
like
bat
origin
camel
intermedi
host
still
circul
four
nonstructur
protein
preclin
explor
antivir
target
sar
mer
coronavirus
reason
well
conserv
novel
coronaviru
rais
hope
approach
howev
patient
enrol
mer
treatment
trial
lopinavir
antiretrovir
proteinas
inhibitor
ritonavir
cytochrom
inhibitor
prolong
halflif
lopinavir
miracl
still
ongo
numer
clinic
trial
regist
china
test
differ
compound
combin
compound
new
coronaviru
infect
test
drug
rang
antivir
nucleotid
analog
viral
proteas
inhibitor
tradit
chines
herbal
medicin
eg
forsythia
deriv
lian
qiao
maxmen
import
start
test
get
inform
patient
enrol
test
current
epidem
stop
suggest
share
standard
clinic
protocol
trial
make
outcom
compar
viru
neutral
test
hand
chines
research
alreadi
done
vitro
efficac
test
novel
coronaviru
promis
effect
observ
nucleotid
analog
remdesivir
antimalaria
compound
chloroquin
show
inhibit
novel
coronaviru
low
micromolar
concentr
rang
remdesivir
act
viral
rna
transcript
postvir
entri
level
chloroquin
need
appli
begin
infect
chloroquin
action
lysosom
membran
might
interfer
viral
entryfus
event
note
nucleotid
analog
remdesivir
better
activ
mer
coronaviru
proteas
inhibitor
lopinavir
combin
ritonavir
cell
cultur
mous
infect
mous
mer
infect
model
remdesivir
improv
pulmonari
function
reduc
lung
viral
load
decreas
sever
lung
patholog
sheahan
et
al
addit
remdesivir
given
prophylact
mer
viruschalleng
rhesu
monkey
significantli
reduc
viral
titr
lung
prevent
lung
patholog
assess
histolog
xray
radiograph
compar
control
anim
de
wit
et
al
treatment
remdesivir
h
viral
challeng
limit
protect
effect
rhesu
monkey
earli
februari
two
random
placebocontrol
clinic
trial
test
therapeut
efficaci
remdesivir
start
china
one
trial
enrol
patient
mild
moder
novel
coronaviru
diseas
clinicaltrialsgov
patient
sever
diseas
clinicaltrialsgov
enrol
plan
complet
end
april
may
respect
import
evidencebas
treatment
proven
control
clinic
trial
must
stress
sinc
sar
epidem
untest
drug
treatment
seem
done
harm
treatment
danchin
person
commun
therapeut
direct
immunopatholog
host
respons
might
treatment
valu
view
cytokin
storm
seen
patient
novel
coronaviru
infect
vaccin
mer
sar
current
avail
case
sar
epidem
current
epidem
must
fought
public
health
measur
first
measur
chines
author
close
wet
seafood
market
wuhan
due
close
contact
live
anim
human
market
offer
ideal
condit
transmiss
zoonot
infect
two
coronaviru
infect
emerg
chines
wet
food
market
strict
hygien
measur
clearli
warrant
howev
consum
meat
product
wild
anim
long
tradit
china
philosophi
medicin
food
homolog
eaten
hungri
food
eaten
ill
medicin
china
pangolin
product
exampl
reput
help
rheumat
meridian
obstruct
liver
diseas
improv
eyesight
li
li
recent
consumpt
meat
wild
anim
becom
sign
social
statu
easi
erad
fals
medic
belief
interdict
might
creat
black
market
therefor
scientist
recommend
strictli
control
instead
forbid
market
protect
healthcar
worker
nosocomi
infect
anoth
urgent
need
sinc
patient
care
alreadi
repres
heavi
burden
health
system
reduct
health
personnel
would
caus
problem
face
mask
insuffici
protect
mask
goggl
protect
gown
need
medic
personnel
chang
et
al
gener
public
frequent
hand
wash
cough
sneez
etiquett
wear
mask
visit
public
place
recommend
howev
scientif
evid
lack
effect
wear
mask
uninfect
person
contrast
proven
effect
hand
wash
respiratori
infect
sar
epidem
contain
mean
syndrom
surveil
isol
patient
quarantin
contact
measur
also
play
import
role
current
epidem
due
sheer
size
necessit
draconian
measur
limit
movement
person
hotspot
infect
result
lockdown
wuhan
particular
small
citi
itali
germani
declar
novel
coronaviru
epidem
public
health
emerg
expand
epidem
stress
test
exist
health
system
includ
industri
countri
also
motiv
strengthen
fundament
research
transspeci
viral
infect
potenti
zoonosi
impact
particularli
bat
chang
environment
condit
viewpoint
citizen
come
protect
live
one
might
ask
whether
one
put
spend
public
health
prevent
research
spend
defenc
budget
